Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ERBB2 Altered Breast Cancer”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Not applicableEnded earlyNCT02963363
What this trial is testing

Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Who this might be right for
HER2 Positive Breast Cancer
Centre Jean Perrin 36
Large-scale testing (Phase 3)Active Not RecruitingNCT05889390
What this trial is testing

Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer

Who this might be right for
HER2-negative Breast Cancer
Semmelweis University 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT01817452
What this trial is testing

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol

Who this might be right for
Breast Cancer
West German Study Group 220
Testing effectiveness (Phase 2)Study completedNCT01142778
What this trial is testing

Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 152
Not applicableStudy completedNCT01934478
What this trial is testing

Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Qingdao Central Hospital 5
Not applicableStudy completedNCT03437837
What this trial is testing

Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Who this might be right for
Breast CancerNeoadjuvant TherapyNeoplasm Staging+5 more
Peking University First Hospital 1,077
Not applicableStudy completedNCT03123263
What this trial is testing

Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer

Who this might be right for
Breast Cancer
Texas Tech University Health Sciences Center, El Paso 60
Not applicableLooking for participantsNCT06127979
What this trial is testing

Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 42
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493
What this trial is testing

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
West German Study Group 1,684
Not applicableNot Yet RecruitingNCT07264985
What this trial is testing

Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

Who this might be right for
Breast CancerDrug-Related Side EffectsDiarrhea
Hubei Cancer Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT07174336
What this trial is testing

Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 920
Early research (Phase 1)Active Not RecruitingNCT06084481
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Who this might be right for
Hepatocellular CarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancers+5 more
AbbVie 302
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Testing effectiveness (Phase 2)Study completedNCT03819010
What this trial is testing

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -

Who this might be right for
Breast Cancer
MedSIR 66
Early research (Phase 1)Looking for participantsNCT04997993
What this trial is testing

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

Who this might be right for
PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Deborah Doroshow 24
Testing effectiveness (Phase 2)Study completedNCT00524277
What this trial is testing

Vaccine Therapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
San Antonio Military Medical Center 456
Testing effectiveness (Phase 2)Active Not RecruitingNCT03161353
What this trial is testing

Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.

Who this might be right for
Breast Cancer
MedSIR 377
Not applicableNot Yet RecruitingNCT07406594
What this trial is testing

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

Who this might be right for
Breast CancerHER-2 Positive Breast Cancer
University of Vermont Medical Center 12
Load More Results